TITLE

Re-examining the efficacy of β-blockers for the treatment of hypertension: a meta-analysis

AUTHOR(S)
Khan, Nadia; McAlister, Finlay A.
PUB. DATE
June 2006
SOURCE
CMAJ: Canadian Medical Association Journal;6/6/2006, Vol. 174 Issue 12, p1737
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In a recently published meta-analysis, investigators asserted that β-blockers should not be used to treat hypertension. Because the pathophysiology of hypertension differs in older and younger patients, we designed this metaanalysis to clarify the efficacy of β-blockers in different age groups. The primary outcome was a composite of stroke, myocardial infarction and death. Methods: We identified randomized controlled trials that evaluated the efficacy of β-blockers as first-line therapy for hypertension in preventing major cardiovascular outcomes. Both authors independently evaluated the eligibility of all trials. Trials enrolling older (mean age at baseline ≥ 60 years) patients were separated from those enrolling younger (mean age < 60 years) patients. Data were pooled using a random effects model. Results: Our analysis incorporated data from 145 811 participants in 21 hypertension trials. In placebo-controlled trials, β-blockers reduced major cardiovascular outcomes in younger patients (risk ratio [RR] 0.86, 95% confidence interval [CI] 0.74-0.99, based on 794 events in 19 414 patients) but not in older patients (RR 0.89, 95% CI 0.75-1.05, based on 1115 events in 8019 patients). In active comparator trials, β-blockers demonstrated similar efficacy to other antihypertensive agents in younger patients (1515 events in 30 412 patients, RR 0.97, 95% CI 0.88-1.07) but not in older patients (7405 events in 79 775 patients, RR 1.06, 95% CI 1.01-1.10), with the excess risk being particularly marked for strokes (RR 1.18, 95% CI 1.07-1.30). Interpretation: β-blockers should not be considered firstline therapy for older hypertensive patients without another indication for these agents; however, in younger patients β-blockers are associated with a significant reduction in cardiovascular morbidity and mortality.
ACCESSION #
21062839

 

Related Articles

  • NICE signals significant changes in BP guidance.  // Pulse;11/5/2005, Vol. 65 Issue 43, p4 

    Reports on the study which found that the ASCOT trial is likely to have a significant impact on new NICE and British Hypertension Society guidelines for hypertension in Great Britain. Confirmation of the need for a wider evaluation of hypertension guidance; Improvement of the first-line therapy;...

  • Hypertension. Stanton, Tony; Brady, Adrian // GP: General Practitioner;5/18/2007, p43 

    The article provides information on the epidemiology, causes and treatment of hypertension. This disease is characterized by sustained high blood pressure (BP) and can trigger coronary heart disease (CHD), left ventricular hypertrophy and cerebrovascular disease. Hypertension is caused by...

  • What is the risk of adverse outcomes in a woman who develops mild hypertension from OCs? Pollara, Trisha; Kelsberg, Gary; Safranek, Sarah // Journal of Family Practice;Nov2006, Vol. 55 Issue 11, p986 

    The article offers information regarding the risk of adverse outcomes in women who are developing mild hypertension from oral contraceptives (OCs). It was stated that there are no studies that specifically examine the risk of adverse outcomes for women who have mild increase in blood pressure...

  • Usefulness of Echocardiographic Left Ventricular Hypertrophy and Silent Ischemia in Predicting New Cardiac Events in Elderly Patients With Systemic Hypertension or Coronary Artery Disease. Aronow, Wilbert S.; Epstein, Stanley; Koenigsberg, Mordecai // Angiology;Mar1990, Vol. 41 Issue 3, p189 

    The authors performed a prospective study to correlate echocardiographic left ventricular hypertrophy (LVH) and silent ischemia (SI) detected by twenty- four-hour ambulatory electrocardiographic monitoring with new cardiac events in 355 patients, mean age eighty-two±eight years, with systemic...

  • Underestimation of Treatment Effect in Crossover Trials. Cleophas, Ton J. // Angiology;Sep1990 Part 1, Vol. 41 Issue 9, p673 

    In crossover trials each subject serves as his own control. For the study of cardiovascular diseases such as hypertension and angina pectoria, properly designed crossover studies are preferred to parallel studies. There is a consider- able between-subject variability of symptoms in some of these...

  • Transient Reversal of Inverted U Waves During Valsalva's Test--A Case Report. Kanemoto, N.; Fukushi, H. // Angiology;Sep1990 Part 1, Vol. 41 Issue 9, p741 

    The authors demonstrate for the first time that resting U wave inversion can become upright transiently during Valsalva's test.

  • CORONARY HEART DISEASE ON THE RISE IN AFRICA. Loock, Magnet; Steyn, Krisela; Becker, Piet; Fourie, Jean // Ethnicity & Disease;Autumn2006, Vol. 16 Issue 4, p1016 

    The article highlights a study which reported that coronary heart disease (CHD) is on the rise in Africa. The study revealed that hypertension and a family history of heart disease are the two risk factors that have the strongest link with CHD. Researchers also found that risk factors predicting...

  • Diabetes and cardiovascular disease among Asian Indians in the United States. Mohanty, Sarita A.; Woolhandler, Steffie; Himmelstein, David U.; Bor, David H. // JGIM: Journal of General Internal Medicine;May2005, Vol. 20 Issue 5, p474 

    Context: Studies, mostly from outside the United States, have found high prevalence of diabetes, coronary heart disease (CHD), and hypertension among Asian Indians, despite low rates of associated risk factors.Objective: To analyze the prevalence of obesity, diabetes,...

  • Drug treatment of hypertension. Reid, John L. // Kidney International Supplement;Jul1993, Issue 42, pS-68 

    Over the last 40 years effective drug treatment of hypertension has become available. Newer classes of drugs offer efficacy with simplicity of dosing regimen and good patient acceptability. However, there is increasing interest in the long-term benefits of treatment, particularly influences on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics